← Back to Search

Microfluidics Device

ZyMot Multi Sperm Separation Device (850 ul) for Assisted Reproductive Technology

N/A
Waitlist Available
Led By Rani Fritz, DO, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up culture day 5 or 6
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if a new method to pick the healthiest sperm can improve embryo quality for couples undergoing fertility treatments. The method uses a special device that only lets the strongest sperm through a tiny filter.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~culture day 5 or 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and culture day 5 or 6 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percentage of Good Quality Blastocyst Formation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ZyMot SeparationExperimental Treatment1 Intervention
Treatment
Group II: Density Gradient CentrifugationActive Control1 Intervention
Control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ZyMot Multi Sperm Separation Device (850 ul)
2021
N/A
~110

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,403 Previous Clinical Trials
855,018 Total Patients Enrolled
Rani Fritz, DO, PhDPrincipal InvestigatorNYU Langone Health
~25 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top